PolitiKit

Promote policies that increase access to telehealth solutions, including primary care and mental health through both private and public administration.

Advocacy to ensure that proposals to develop or amend federal legislation, regulations, policies or programs that directly or indirectly impact the post-secondary system reflect the needs of universities and support our research and education mission.

Canada Pension Plan – Disability with respect to eligibility for persons with MS and other chronic and episodic disabilities

Comprehensive disability income programs, with respect to persons with MS and other chronic and episodic disabilities

Federal Budget: Allocate funding for the Canada Disability Benefit, the Employment Insurance Sickness Benefit; health research; access to treatment and care; and other budgetary policy as it relates to MS.

We ask the federal government to fund MS research in partnership with MS Canada, leveraging our connections and expertise to focus and further our understanding of MS, pursue leading-edge research on repair and regeneration, and explore prevention strategies, including targeting the Epstein-Barr virus (EBV).

Home care, with respect to creation with provincial/ territorial governments programs relating to increased home care for persons with MS and other disabilities/ diseases and the support of caregivers

Disability Tax Credit with respect to making it refundable and ensuring eligibility for Canadians with episodic disabilities

Bill C-64, An Act Respecting Pharmacare with respect for persons with MS and other chronic conditions and disabilities

Access to treatments as it relates to the current regulatory and price negotiation processes to enhance timely access to all Health Canada approved MS disease-modifying therapies, with respect to the National Strategy for Drugs for Rare Diseases and national pharmacare.

Canada Health Act and regulations, as it relates to long-term and home care

Support family doctors with teams, as that is a key enabler to providing high quality primary care

Connected Care for Canadians Act (BILL S-5) : Urging federal policy makers to adopt this legislation quickly and to ensure that it is supported by a robust set of regulations.

Fulfill key investments to support family doctors, promised by the Liberal Party during the 2025 Federal elections. This includes initiatives to provide admin burden relief, set up a new FP practice fund, and create new residency seats.

Provide CFPC's perspective on Federal Budget 2025's initiative to “Improving Access to Health Care in the Arctic and the North”.

Support family doctors with teams, as that is a key enabler to providing high quality primary care

Provide CFPC's perspective on Federal Budget 2025's initiative to “Improving Access to Health Care in the Arctic and the North”.

Addressing administrative burden: Administrative burden consistently ranks as a top concern for family physicians. This time comes in the way of providing patient care. One of the significant sources of administrative burden for family physicians is filling out federal health forms.

Fulfill key investments to support family doctors, promised by the Liberal Party during the 2025 Federal elections. This includes initiatives to provide admin burden relief, set up a new FP practice fund, and create new residency seats.

Expand the Canada Student Loan Forgiveness Program to include front-line allied health care professionals, such as Doctors of Chiropractic.

Inclusion of chiropractors as recognized qualified practitioners to issue the Disability Tax Credit Certificate(T2201).

Improve access to chiropractic care for Indigenous peoples, particularly by adding coverage for chiropractic services under the Non-Insured Health Benefits Program.

DIVERSE TALENT BASE: Advocate for better support for a diversified talent base in Canada, with a focus on Indigenous researchers, Black and people of colour researchers, early-career researchers, and other underrepresented and equity-deserving groups.

DIGITAL HEALTH SYSTEM: Advocate for investment in the digitalization of our health system so that high-quality data and digital technologies support healthcare decisions, empower patients as partners, and drive research and innovation.

GOVERNMENT FUNDING: Advocate for increased health research funding through the three granting councils (Canadian Institutes of Health Research, Social Sciences and Humanities Research Council, and Natural Sciences and Engineering Research Council of Canada) and the Canada Research Coordinating Committee.

INDUSTRY: Advocate for policies that enhance the health and biosciences sector’s capacity to do business in Canada and to invest in Canadian health research and commercialization.

YOUNG TRAINEES AND STUDENTS: Advocate for continued support of and investment in the next generation of highly skilled researchers through the federal awards system for doctoral students, post-doctoral trainees and fellows.

RESEARCH HOSPITALS: Advocate for direct support and stability for Canada's academic health science centres and research hospitals that will further enable them to fulfill their strategically critical contribution to Canada's health and economic security.

Innovation Agenda, particularly with respect to initiatives to support and attract investments in the life sciences sector

Canada Agency for Drugs and Technologies in Health (CADTH) as it relates to health economics assessment and recommendations made on new medicines.

INDUSTRY - Encouraging the government to strengthen regulatory cooperation and alignment through bodies like the Regulatory Cooperation Council (RCC); modernizing and streamlining regulatory frameworks to reduce red tape for businesses; supporting innovation by fostering regulatory flexibility that accommodates emerging technologies and industries; and enhancing the competitiveness of Canadian businesses by promoting harmonized standards across borders, facilitating smoother trade and market access.

Free trade agreements as they relate to the biopharmaceutical industry

Policies and frameworks to accelerate access to innovative medicines post-Health Canada approval, including efforts to reduce time-to-reimbursement and streamline federal/provincial listing processes

Communications regarding opportunities to speed patient access to live-saving medicines on publicly-funded drug formularies in Canada by reducing red tape.

Engagement with Health Canada’s Regulatory Operations & Enforcement branch regarding supply chain resilience & integrity; mitigating and alleviating drug shortages.

National caregiving strategy including necessary policy, program, and budgetary allocations.